Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

What is Beckwith-Wiedemann syndrome? Genetics and treatment

What is Beckwith-Wiedemann syndrome? Genetics and treatment

What is Beckwith-Wiedemann syndrome?

Beckwith-Wiedemann syndrome (BWS) is a growth-regulation disorder. Its most common features include macrosomia (large body size), macroglossia (a large tongue), abdominal-wall defects, increased risk of childhood tumors, kidney abnormalities, hypoglycemia (low blood sugar) in newborns, and abnormal ear creases and pits. Children with BWS may also have hemihyperplasia, in which some parts of the body are larger than those on the opposite side.

What are the symptoms of Beckwith-Wiedemann syndrome?

Macrosomia and macroglossia, major features of BWS, are usually present at birth. Abdominal-wall defects such as omphalocele, which causes protrusion through the navel, are also present at birth and usually require surgery in the newborn. Mothers of children with BWS may experience pregnancy problems such as polyhydramnios (excess fluid protecting the baby in the womb) and premature birth. An unusually large placenta and long umbilical cord may also occur.

What is Beckwith Wiedemann syndrome? Infographic

The increased growth rate usually slows during childhood. Intellectual development is generally normal, and adults with BWS usually do not experience medical problems related to their condition.

What causes BWS?

The mechanisms of the gene mutations causing BWS are complex. BWS is classified as an imprinting disorder. To understand imprinting, it is important to know that each person receives two copies of a gene, one from each parent. Usually, both copies are expressed. Imprinting, however, refers to the process of deactivating one copy of each gene so that only one copy is normally expressed. Imprinting disorders result from inappropriate functioning of gene expression in the imprinted gene sequence. In some people, both copies may be expressed; in others, neither may be expressed. Depending on the genes affected, a person’s tumor risk may range from approximately 3% to 43%.

The most common cause of BWS is a change in DNA methylation.

In approximately 20% of BWS cases, a person has inherited both copies of a particular gene from their father, making some genes more dominant than others. Other causes include, at a rate of 10%, genetic mutations, and unknown causes at a rate of 13%-15%.

It is important for doctors to identify the specific genetic mutation involved because this affects the particular increase in tumor type and the appropriate medical monitoring program.

BWS is a genetic condition involving changes in genes on chromosome 11 in a region called the short arm (11p15.5). This is the area containing two genes called insulin-like growth factor II (IGF-2) and cyclin-dependent kinase inhibitor (CDKN1C). In approximately 85% of cases, the genetic changes causing BWS occur sporadically (by chance in people without a family history). In approximately 10% to 15% of cases, the genetic changes may be inherited. This means that BWS risk can pass from generation to generation within a family. The inherited condition is caused by "germ / germline mutations."

How is BWS passed to later generations?

The 10% to 15% of inherited BWS follows an autosomal dominant inheritance pattern. Normally, each cell has two copies of each gene, one inherited from each parent. In autosomal dominant inheritance, a mutation occurs in only one copy. A parent with a gene mutation can pass on either a normal gene copy or the mutated gene copy. A child of a parent with the mutation therefore has a 50% chance of inheriting it. A brother, sister or parent of a person with the mutation also has a 50% chance of carrying the same mutation. However, if parents test negative for the mutation, meaning it is not found in their test results, the risk to siblings is significantly reduced, although their own risk may still be higher than average.

Some options are available for people with a hereditary cancer syndrome who wish to have children. Preimplantation genetic diagnosis (PGT), a medical procedure performed with in vitro fertilization (IVF), can allow them to have children without passing on a specific gene mutation. The woman’s eggs are removed and fertilized in a laboratory. When embryos reach a certain size, approximately 8 cells, 1 cell is removed and tested for the hereditary condition in question. Parents may then choose to transfer embryos without the mutation into the woman’s uterus. PGT has been used for more than twenty years to prevent various hereditary cancer-predisposition syndromes. However, it is a complex procedure involving financial, physical and emotional factors that should be considered before starting PGT.

How common is BWS?

BWS has been found at different rates in different populations. Approximately one in 13,700 people is thought to have BWS. Some researchers suggest this may be an underestimate.

How is BWS diagnosed?

BWS is diagnosed clinically, meaning primarily from physical signs. It is suspected in children who are larger than expected for their age, especially if growth is not symmetrical on the right or left side of the body.

An unusually large tongue and abdominal-wall defects, particularly omphalocele, are also considered typical BWS features. Many other features may occur in some children with BWS, but not every child has every feature. Features are listed as major (common) or minor (less common). In general, at least 1 major and 2 minor features together are considered necessary to diagnose BWS. Major and minor features are as follows:

Major / main features

  • Macrosomia (large body size)
  • Macroglossia (large tongue)
  • Omphalocele (protrusion through the navel)
  • Hemihyperplasia (some body parts being larger than those on the opposite side)
  • Abnormal earlobe creases or pits
  • Visceromegaly (enlargement of one or more abdominal organs)
  • Embryonal tumor (Wilms tumor, hepatoblastoma, neuroblastoma, rhabdomyosarcoma)
  • Adrenocortical tumor (adrenal gland tumor)
  • Kidney abnormalities
  • Cleft palate
  • Family history of BWS

Minor features

  • Polyhydramnios (excess amniotic fluid protecting the baby)
  • Premature birth
  • Hypoglycemia (low blood sugar)
  • Advanced bone age
  • Heart problems
  • Diastatsis recti (separation of the right and left sides of the main abdominal muscle)
  • Hemangioma, a noncancerous tumor made of blood vessels
  • Facial nevus flammeus, a skin hemangioma also called a "port-wine stain"
  • Characteristic facial features
  • Identical twin

Early diagnosis of BWS is important because affected children have a higher risk of developing certain tumors, including Wilms tumor and hepatoblastoma as examples.

To detect gene mutations associated with BWS, genetic tests are available, but they are complex. All families considering genetic testing for BWS are advised to meet with a clinical geneticist, a physician trained in genetics, and a genetic counselor who can explain and coordinate testing. Currently available genetic testing methods can identify 80% of the genetic mutations causing BWS.

What are the estimated cancer risks associated with BWS?

Several different tumor types, both cancerous and benign (noncancerous), have been reported in children with BWS. The estimated risk of a child with BWS developing a tumor is 5% to 10%in these estimates.

Tumors are very rare after age 10, and the risk of any one tumor decreases over time until it is similar to that of the general population. Cancer risk is highest in children with hemihyperplasia (some body parts larger than those on the other side) and visceromegaly (enlargement of one or more abdominal organs) compared with those without these features. In fact, those with hemihyperplasia may have a risk 4 times that of people with BWS without hemihyperplasia.

The most common tumor types in BWS are:

  • Wilms tumor (a kidney tumor, accounting for approximately 40% of cases; Wilms tumors may also occur in both kidneys in 20% of cases)
  • Hepatoblastoma (liver tumor)
  • Adrenocortical carcinoma (adrenal gland tumor, approximately 20% of cases)
  • Neuroblastoma
  • Rhabdomyosarcoma

What are the screening options for BWS?

Screening recommendations for people with BWS primarily aim to detect hepatoblastoma and Wilms tumor. Current recommended screening for people known or suspected to have BWS is as follows:

  • At diagnosis, an abdominal magnetic resonance imaging (MRI) or computed tomography (CT) scan
  • Abdominal ultrasound may be performed every 3 months until age 4 to screen for hepatoblastoma and Wilms tumor. After age 4, imaging may be limited to kidney ultrasound until age 8.
  • Serum alpha-fetoprotein blood testing every 6 weeks, or at least every 3 months, until age 4
  • Regular physical examinations, including abdominal examination; frequency is determined by your doctor.

If a child has an identical twin without BWS signs, the twin should still be screened with ultrasound and serum alpha-fetoprotein blood tests as described above.

Screening for hypoglycemia (low blood sugar) is also important in infancy. Children with BWS may need evaluation by doctors specializing in craniofacial surgery to determine whether surgery is needed to reduce tongue size. Support may be needed for feeding difficulties in infancy and speech development in childhood. Children with significant hemihyperplasia may need assessment by an orthopedist (bone doctor).

Screening recommendations may change over time as new technologies are developed and more is learned about BWS. It is important to discuss appropriate screening tests with your doctor.

Questions to ask your healthcare team

If you are concerned about your child’s cancer risk, talk with your healthcare team. It may help to bring someone to appointments to take notes. You can ask the following questions:

  • What is my child’s risk of developing cancer?
  • What can I do to reduce my child’s cancer risk?
  • What are my options for cancer screening?

If you are concerned about your family history and think you, your child or other relatives may have BWS, you can ask:

  • Does our family history increase my child’s risk of BWS or a cancerous or benign tumor?
  • Could my family have BWS?
  • Should I see a genetic counselor?
  • Should I consider genetic testing?

Sources

Beckwith-Wiedemann Syndrome. Approved by the Cancer.Net Editorial Board, 03/2020. https://www.cancer.net/cancer-types/beckwith-wiedemann-syndrome

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

What is Beckwith-Wiedemann syndrome? Genetics and treatment

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy